STEM CELL STOCKS

[dlry]

National Securities Corporation and MD Becker Partners To Host Inaugural Stem Cell Conference June 1, 2010 In New York City


"Despite recent progress, investors have largely ignored the stem cell sector because the technical challenges have seemed insurmountable," said Jason Kolbert, Managing Director, Head of Healthcare Research, at National Securities Corporation. "However, it is fair to compare the current state of the stem cell industry to the field of monoclonal antibodies more than a decade ago. In a similar manner, we expect advancements in stem cell science to lead to dramatic breakthroughs in the near future, which makes the SCIENCE quite timely."

http://tinyurl.com/2flhv73

[dlry]

Look where the funding came from for this deal...could be telling for the sector as far as institutional money flows?

Stem cell legend attracts $40M round for preclinical testing tech

Madison, WI-based Cellular Dynamics International has raised a $40.6 million Series B to expand on the commercialization of its work harvesting human stem cell lines for preclinical drug testing. Founded by stem cell legend James Thomson from the University of Wisconsin, Cellular Dynamics--a 2008 Fierce 15 company--has been a pioneer in the move to use stem cell technology for more accurate preclinical drug testing.

Read more: http://http://tinyurl.com/23aenwc

[dlry]

Thursday Apr 29 2010 Stanford News
Whole genome sequencing data vaults into clinic
By Krista Conger

"We're at the dawn of a new age in genomics," said Quake, who is the Lee Otterson Professor of Bioengineering. "Information like this will enable doctors to deliver personalized health care like never before. Patients at risk for certain diseases will be able to receive closer monitoring and more frequent testing, while those who are at lower risk will be spared unnecessary tests. This will have important economic benefits as well, because it improves the efficiency of medicine."

http://tinyurl.com/2fklmvh

[dlry]

Great Video of Jaw Bone Grown From Stem Cells

Researchers at Columbia University grabbed our attention last year when they managed to grow a fully viable section of the jawbone from human stem cells. The temporomandibular joint (TMJ) is one of the more complex bone structures in the body and it was quite a feat to grow one in vitro. Now, Reuters has produced a great video of Columbia’s work, including a look at the bioreactor used and a brief interview with the head of the project, Gordana Vunjak-Novakovic.

http://tinyurl.com/2bejvjg

[dlry]

Stem cells raise hope for treatment for multiple sclerosis patients

05 May 2010

Thousands of MS sufferers could benefit from a revolutionary treatment that injects them with stem cells taken from their own bone marrow.

http://tinyurl.com/37sa7h8

[dlry]

They used placenta stem cells (psti) to heal this guys foot.

http://abclocal.go.com/wtvd/video?id=7429762

[dlry]

Experts laud potential of Athersys stem cell therapy MultiStem

Doctors and researchers at the Athersys Inc. (NASDAQ: ATHX) investor meeting in New York City expressed hope that the company’s stem cell therapy — MultiStem — could raise the ceiling on care for heart attack, stroke and some cancer patients, among others.

Biopharmaceutical company Athersys invited nearly a dozen stem cell experts — including Ruth McKernan, head of Pfizer Regenerative Medicine, with which Athersys is working on a therapy for inflammatory bowel disease — to its annual investor day on Friday.

http://tinyurl.com/2wx8xq4

[dlry]

Scientists Create First Synthetic Cell, Opening New Era in Biology





By ROBERT LEE HOTZ

Heralding a new era in biology, scientists for the first time have created a synthetic cell, completely controlled by man-made genetic instructions, which can survive and reproduce itself, researchers at the private J. Craig Venter Institute announced Thursday.


"We call it the first synthetic cell," said genomics pioneer Craig Venter, who oversaw the project. "These are very much real cells."

Created at a cost of $30 million, this experimental one-cell organism opens the way to the manipulation of life on a previously unattainable scale, several researchers and ethics experts said. Scientists have been altering DNA piecemeal for a generation, producing a menagerie of genetically engineered plants and animals, but the ability to craft an entire organism offers a new power over life, they said.


The accomplishment, documented in the peer-reviewed journal Science, may stir anew nagging questions of ethics, law and public safety about artificial life that biomedical experts have been publicly debating for more than a decade.

"This is literally a turning point in the relationship between man and nature," said molecular biologist Richard Ebright at Rutgers University, who wasn't involved in the project. "For the first time, someone has generated an entire artificial cell with pre-determined properties."

David Magnus, director of the Stanford University Center for Biomedical Ethics, said, "It has the potential to transform genetic engineering. The research is going to explode once you can create designer genomes."



Leery of previous moral and ethical questions about whether it is right to manipulate life forms—raised with the advent of cloning, stem-cell technology and genetic engineering—other researchers groped for neutral terms to describe the experimental cell. "I don't think it represents the creation of an artificial life form," said biomedical engineer James Collins at Boston University. "I view this as an organism with a synthetic genome, not as a synthetic organism. It is tough to draw where the line is."

Although the new cell, a form of bacteria, was conceived solely as a demonstration project, several biologists were certain that the laboratory technique used to birth it would soon be applied to other strains of bacteria with commercial potential. "I think this quickly will be applied to all the most important industrial bacteria," said biologist Christopher Voigt at the University of California, San Francisco, who is developing microbes that help make gasoline.

Already several companies are seeking to take advantage of the new field, called synthetic biology, which combines chemistry, computer science, molecular biology, genetics and cell biology to breed industrial life forms that can secrete fuels, vaccines or other saleable products.

Indeed, Synthetic Genomics Inc., a company founded by Dr. Venter, funded the experiments and owns the intellectual property rights to the cell-creation techniques. The company has a $600 million contract with Exxon Mobil Corp. to design algae that can capture carbon dioxide and make fuel.

Although patents on single genes now face legal challenges, Dr. Venter said he intended to patent his experimental cells. "They are pretty clearly human inventions," he said.



The announcement Thursday was the culmination of a project Dr. Venter and his colleagues have pursued since 1995. In a series of peer-reviewed papers, the group has openly published the interim technical steps. So far, that research has withstood scrutiny. The latest research was reviewed by a panel of independent scientists and the research materials are made public as a condition of publication in the journal.

To make the synthetic cell, a team of 25 researchers at labs in Rockville, Md., and San Diego, Calif., led by bioengineer Daniel Gibson and Dr. Venter essentially turned computer code into a new life form. They started with a species of bacteria called Mycoplasma capricolum and, by replacing its genome with one they wrote themselves, turned it into a customized variant of a second species called Mycoplasma mycoides, they reported.


To begin, they wrote out the creature's entire genetic code as a digital computer file documenting more than one million base pairs of DNA in a biochemical alphabet of adenine, cytosine, guanine and thymine. They edited that file, adding new code, and then sent that electronic data to a DNA sequencing company called Blue Heron Bio in Bothell, Wash., where it was transformed into hundreds of small pieces of chemical DNA, they reported.

To assemble the strips of DNA, the researchers said they took advantage of the natural capacities of several types of existing cells to meld genes and chromosomes: They used yeast and e. coli bacteria to stitch those short sequences into ever-longer fragments until they had assembled the complete genome, as the entire set of an organism's genetic instructions is called.

They transplanted that master set of genes into an emptied cell, where it converted the cell into a different species.

"We make a genome from four bottles of chemicals; we put that synthetic genome into a cell; that synthetic genome takes over the cell," said Dr. Gibson. "The cell is entirely controlled by that new genome."

The cells reveal nothing of their novelty to the naked eye. They are so primitive they even lack a cell membrane.

The scientists didn't give the new organism its own species name, but they did give its synthetic genome an official version number, like the prototype of a computer software operating system. The genome is called Mycoplasma mycoides JCVI-syn1.0.

To set this novel bacterium—and all its descendants—apart from any natural creation, Dr. Venter and his colleagues wrote their names into the creature's chemical DNA code, along with three apt quotations. "They put some poetry into the genome," said Dr. Voigt.

The scientists also encoded an email address and the name of a website, so that anyone who successfully deciphered the quotations hidden in the genome could notify the scientists.

More importantly, these genetic watermarks allow the researchers to pick out their cells from among more natural varieties and, eventually, to assert ownership. "You have to have a way of tracking it," said Stanford ethicist Mildred Cho, who has studied the issues posed by the creation of such organisms.

*Update: We’ve included the Science interview with Venter after the break.
http://tinyurl.com/2cz9lmk

[dlry]

Talk of the Nation

Is Stem Cell Research Making Progress?

May 21, 2010 ... But we've heard a lot of news about stem cells. Where do we stand? What's the state of stem cell research? Are we going to see any real breakthroughs? ...

http://www.npr.org/templates/story/stor ... =127037405


http://tinyurl.com/25lxqa8

[dlry]

This is true contribution to society...

UCI researchers create retina from human embryonic stem cells

Complex tissue structure -- a first ? offers hope to millions with degenerative eye disorders

Irvine, Calif., May 26, 2010 ? UC Irvine scientists have created an eight-layer, early-stage retina from human embryonic stem cells, the first three-dimensional tissue structure to be made from stem cells.

It also marks the first step toward the development of transplant-ready retinas to treat eye disorders such as retinitis pigmentosa and macular degeneration that affect millions.

"We made a complex structure consisting of many cell types," said study leader Hans Keirstead of the Reeve-Irvine Research Center and the Sue and Bill Gross Stem Cell Research Center at UCI. "This is a major advance in our quest to treat retinal disease."

http://tinyurl.com/3xo7cec